The 54 linked references in paper A. Faenko P., A. Vatazin V., A. Kildjushevskiy V., V. Fedulkina V., А. Фаенко П., А. Ватазин В., А. Кильдюшевский В., В. Федулкина А. (2017) “ФОТОФЕРЕЗ ПРИ ТРАНСПЛАНТАЦИИ ПОЧЕК // PHOTOPHERESIS DURING KIDNEY TRANSPLANTATION” / spz:neicon:nefr:y:2016:i:6:p:42-48

  1. 14; 4: 49-56] 2. Johnston O, Rose C, Landsberg D et al. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007; 7(8): 1961-1967. doi: 10.1111/j.1600-6143.2007.01884.x
  2. Zambon JP, Magalhaes RS, Ko I et al. Kidney regeneration: Where we are and future perspectives. World J Nephrol 2014; 3(3): 24-30. doi: 10.5527/wjn.v3.i3.24
  3. Yu H, Kim HS, Baek CH et al. Risk Factors for Hypertension After Living Donor Kidney Transplantation in Korea: A Multivariate Analysis. Transplant Proc 2016; 48(1): 88-91. doi: 10.1016/j. transproceed.2015.12.020
  4. Peter W, Edelson RL. New Therapies for Cutaneous T-Cell Lymphoma. Arch Dermatol 1987; 123(2): 189-191. doi:10.1001/ archderm.1987.01660260059012
  5. Otman SG, Edwards C, Pearse AD et al. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy. Br J Dermatol 2006; 154(5): 963-8. doi: 10.1111/j.1365-2133.2006.07171.x
  6. Jung AG, Bertsch HP, Schoen MP et al. A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP). Hautarzt 2010; 61(6): 514-517. doi: 10.1007/s00105-010-1924-9
  7. Andreu-Ullrich H. Miscellaneous indications for extracorporeal photochemotherapy (ECP). Transfus Apher Sci 2014;50(3): 363-369. doi: 10.1016/j.transci.2014.04.007
  8. Adamski J, Kinard T, Ipe T et al. Extracorporeal photopheresis for the treatment of autoimmune diseases. Transfus Apher Sci 2015; 52(2): 171-182. doi: 10.1016/j.transci.2015.02.005
  9. Knobler R, Berlin G, Calzavara-Pinton P et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014; 28(1): 1-37. doi: 10.1111/jdv.12311
  10. Perotti C, Sniecinski I. A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going! Transfus Apher Sci 2015; 52(3): 360-368. doi: 10.1016/j.transci.2015.04.011
  11. Schwartz J, Winters JL, Padmanabhan A et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidencebased approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28(3): 145-284. doi: 10.1002/jca.21276
  12. Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992; 53(4): 808-815. doi: 10.1097/00007890199204000-00021
  13. Barten MJ, Dieterlen MT. Extracorporeal photopheresis after heart transplantation. Immunotherapy 2014;6(8):927-944. doi: 10.2217/imt.14.69
  14. Dieterlen MT, Bittner HB, Pierzchalski A et al. Immunological monitoring of extracorporeal photopheresis after heart transplantation. Clin Exp Immunol 2014; 176(1): 120-128. doi: 10.1111/cei.12254
  15. Kapadia E, Wong E, Perez-Albuerne E et al. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease. Pediatr Blood Cancer 2015; 62(8): 1485-1488. doi: 10.1002/pbc.25487
  16. Kitko CL, Levine JE. Extracorporeal photopheresis in prevention and treatment of acute GVHD. Transfus Apher Sci 2015; 52(2): 151-156. doi: 10.1016/j.transci.2015.02.001
  17. Calore E, Marson P, Pillon М et al. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience. Biol Blood Marrow Transplant 2015; 21(11): 1963-1972. doi: 10.1016/j. bbmt.2015.07.007
  18. Benden C, Speich R, Hofbauer GF et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008; 86(11): 1625-1627. doi: 10.1097/TP.0b013e31818bc024
  19. Sato M, Waddell TK, Wagnetz U et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30(7): 735-742. doi: 10.1016/j. healun.2011.01.712
  20. Jaksch P, Scheed A, Keplinger M et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012; 31(9): 950-957. doi: 10.1016/j.healun.2012.05.002
  21. Urbani L, Mazzoni A, Colombatto P et al. Potential applications of extracorporeal photopheresis in liver transplantation. Transplant Proc 2008; 40(4): 1175-1178. doi: 10.1016/j. transproceed.2008.03.071
  22. Urbani L, Mazzoni A, Bianco I et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008; 23(2): 55-62. doi: 10.1002/jca.20156
  23. Urbani L, Mazzoni A, Bindi L et al. A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation. Clin Transplant 2009; 23(6): 853-860. doi: 10.1111/j.13990012.2009.00957.x
  24. Baron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.x
  25. Kusztal M, Kłak R, Krajewska M et al. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Transplant Proc 2011; 43(8): 2941-2942. doi: 10.1016/j.transproceed.2011.08.034
  26. Schmid D, Grabmer C, Streif D et al. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang 2015; 108(1): 8288. doi: 10.1111/vox.12200
  27. Holtick U, Wang XN, Marshall SR et al. In vitro PUVA treatment preferentially induces apoptosis in alloactivated T cells. Transplantation 2012; 94(5): 31-34. doi: 10.1097/ TP.0b013e31825f4454
  28. Heshmati F. Updating ECP action mechanisms. Transfus Apher Sci 2014; 50(3): 330-339. doi: 10.1016/j.transci.2014.04.003
  29. Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of all reactive activated T cells than of nonalloreactive resting T cells in GvHD. Transplantation 2010; 90(11): 1232–1238. doi: 10.1097/TP.0b013e3181fa4eb6
  30. Yoo EK, Rook AH, Elenitsas R et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107(2): 235-242. doi: 10.1111/1523-1747.ep12329711
  31. Setterblad N, Garban F, Weigl R et al. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death. Transfusion 2007; 48(1): 169-177. doi: 10.1111/j.15372995.2007.01502.x
  32. Usharauli D. Dendritic cells and the immunity/tolerance decision. Med Hypotheses 2005; 64(1): 112-113. doi: 10.1016/j. mehy.2004.02.061
  33. Morelli AE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 2006; 6(2): 254-261. doi: 10.1111/j.16006143.2005.01197.x
  34. Bittencourt MC, Perruche S, Contassot E et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98(1): 224-230. doi: 10.1182/blood.V98.1.224
  35. Kleinclauss F, Perruche S, Masson E et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2005; 13(1): 41-52. doi:10.1038/sj.cdd.4401699
  36. Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101(2): 611-620. doi: 10.1182/ blood-2002-06-1769
  37. Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease. Transplantation 2010; 90(11): 1232-1238. doi: 10.1097/ TP.0b013e3181fa4eb6
  38. Peritt D. Potential mechanisms of action of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplantation 2006; 12: 7-12. doi: 10.1016/j.bbmt.2005.11.005
  39. Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008; 57(4): 177-183. doi: 10.2302/kjm.57.177
  40. Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195(10): 1289-1302. doi: 10.1084/jem.20020161
  41. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graftversus-host disease. Blood 2002; 100(3): 941-947. doi: 10.1182/ blood-2002-01-0068
  42. Baron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.x
  43. Inaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998; 188(11): 2163-2173. doi: 10.1084/jem.188.11.2163
  44. Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100(1): 174-177. doi: 10.1182/ blood.V100.1.174
  45. Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006; 46(1): 55-65. doi: 10.1111/j.15372995.2005.00670.x
  46. Vogel I, Kasran A, Cremer J et al. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity. Eur J Immunol 2015; 45(6): 1832-1841. doi: 10.1002/eji.201445190
  47. Coutinho A, Caramalho I, Seixas E et al. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Current Topics in Microbiology and Immunology 2005; 293: 43-71. doi: 10.1007/3-540-27702-1_3
  48. Hu G, Liu Z, Zheng C et al. Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells. Cell Mol Immunol 2010; 7(6): 414-418. doi: 10.1038/cmi.2010.39
  49. Viglietta V, Baecher-Allan C, Weiner HL et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199(7): 971-979. doi: 10.1084/jem.20031579
  50. Yang XF. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets. Front Biosci 2008; 13: 1472-1499. doi: 10.2741/2775
  51. Dhaeze T, Peelen E, Hombrouck A et al. Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis. J Immunol 2015; 195(3): 832-840. doi: 10.4049/jimmunol.1500759
  52. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166(6): 3789-3796. doi: 10.4049/jimmunol.166.6.3789
  53. Cohen JL, Trenado A, Vasey D et al. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versushost disease. J Exp Med 2002; 196(3): 401-406. doi: 10.1084/ jem.20020090
  54. Meloni F, Cascina A, Miserere S et al. Peripheral CD4(+) CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39(1): 213-217. doi: 10.1016/j.transproceed.2006.10.227 Сведения об авторах: